The mechanisms of resistance to second- and third-generation ALK inhibitors and strategies to overcome such resistance.
Expert Rev Anticancer Ther. 2021 Sep;21(9):975-988. doi: 10.1080/14737140.2021.1940964. Epub 2021 Jun 21.
Expert Rev Anticancer Ther. 2021.
PMID: 34110954
Review.